UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - NYSE:UTI - US9139151040 - Common Stock
34.02 USD
-0.47 (-1.36%)
34.8 USD
+0.78 (+2.29%)
Taking everything into account, UTI scores 6 out of 10 in our fundamental rating. UTI was compared to 77 industry peers in the Diversified Consumer Services industry. UTI scores excellent on profitability, but there are some minor concerns on its financial health. UTI is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make UTI suitable for growth investing!
1. Profitability
1.1 Basic Checks
UTI had positive earnings in the past year.
UTI had a positive operating cash flow in the past year.
UTI had positive earnings in each of the past 5 years.
UTI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
UTI's Return On Assets of 8.52% is fine compared to the rest of the industry. UTI outperforms 79.22% of its industry peers.
UTI has a better Return On Equity (20.57%) than 87.01% of its industry peers.
UTI has a better Return On Invested Capital (10.86%) than 84.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UTI is below the industry average of 9.48%.
The 3 year average ROIC (5.11%) for UTI is below the current ROIC(10.86%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROIC | 10.86% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
1.3 Margins
UTI has a Profit Margin of 7.79%. This is in the better half of the industry: UTI outperforms 68.83% of its industry peers.
In the last couple of years the Profit Margin of UTI has grown nicely.
Looking at the Operating Margin, with a value of 10.44%, UTI is in the better half of the industry, outperforming 70.13% of the companies in the same industry.
In the last couple of years the Operating Margin of UTI has grown nicely.
UTI has a Gross Margin (49.65%) which is in line with its industry peers.
UTI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% |
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
2. Health
2.1 Basic Checks
UTI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UTI has more shares outstanding than it did 1 year ago.
UTI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, UTI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.22 indicates that UTI is not in any danger for bankruptcy at the moment.
UTI has a better Altman-Z score (4.22) than 85.71% of its industry peers.
UTI has a debt to FCF ratio of 0.99. This is a very positive value and a sign of high solvency as it would only need 0.99 years to pay back of all of its debts.
UTI's Debt to FCF ratio of 0.99 is amongst the best of the industry. UTI outperforms 85.71% of its industry peers.
UTI has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
UTI has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: UTI outperforms 57.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Altman-Z | 4.22 |
ROIC/WACC1.29
WACC8.41%
2.3 Liquidity
UTI has a Current Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
UTI has a Current ratio (1.00) which is comparable to the rest of the industry.
UTI has a Quick Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
UTI's Quick ratio of 1.00 is in line compared to the rest of the industry. UTI outperforms 48.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
UTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 128.00%, which is quite impressive.
The Earnings Per Share has been growing by 28.35% on average over the past years. This is a very strong growth
UTI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.56%.
UTI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.19% yearly.
EPS 1Y (TTM)128%
EPS 3Y28.35%
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)14.56%
Revenue growth 3Y29.79%
Revenue growth 5Y17.19%
Sales Q2Q%15.12%
3.2 Future
Based on estimates for the next years, UTI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.50% on average per year.
UTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.46% yearly.
EPS Next Y44.42%
EPS Next 2Y12.83%
EPS Next 3Y12.5%
EPS Next 5YN/A
Revenue Next Year14.42%
Revenue Next 2Y11.32%
Revenue Next 3Y10.46%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 29.84 indicates a quite expensive valuation of UTI.
Compared to the rest of the industry, the Price/Earnings ratio of UTI is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.08, UTI is valued at the same level.
Based on the Price/Forward Earnings ratio of 36.11, the valuation of UTI can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UTI is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, UTI is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.84 | ||
| Fwd PE | 36.11 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UTI indicates a somewhat cheap valuation: UTI is cheaper than 62.34% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, UTI is valued a bit cheaper than 64.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.77 | ||
| EV/EBITDA | 14.62 |
4.3 Compensation for Growth
UTI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UTI may justify a higher PE ratio.
A more expensive valuation may be justified as UTI's earnings are expected to grow with 12.50% in the coming years.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y12.83%
EPS Next 3Y12.5%
5. Dividend
5.1 Amount
UTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
34.02
-0.47 (-1.36%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.48%
Inst Owner Change-0.5%
Ins Owners2.24%
Ins Owner Change-1.76%
Market Cap1.85B
Revenue(TTM)809.53M
Net Income(TTM)63.10M
Analysts81.82
Price Target38.18 (12.23%)
Short Float %3.62%
Short Ratio2.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.27%
Min EPS beat(2)69.26%
Max EPS beat(2)73.27%
EPS beat(4)4
Avg EPS beat(4)69.47%
Min EPS beat(4)12.21%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)80.23%
EPS beat(12)10
Avg EPS beat(12)129.78%
EPS beat(16)14
Avg EPS beat(16)215.22%
Revenue beat(2)2
Avg Revenue beat(2)2.83%
Min Revenue beat(2)1.15%
Max Revenue beat(2)4.51%
Revenue beat(4)4
Avg Revenue beat(4)2.54%
Min Revenue beat(4)1.15%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.39%
Revenue beat(12)11
Avg Revenue beat(12)2.98%
Revenue beat(16)15
Avg Revenue beat(16)3.43%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.46%
EPS NQ rev (3m)-21%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)1.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.84 | ||
| Fwd PE | 36.11 | ||
| P/S | 2.29 | ||
| P/FCF | 24.77 | ||
| P/OCF | 17.18 | ||
| P/B | 6.03 | ||
| P/tB | 7.1 | ||
| EV/EBITDA | 14.62 |
EPS(TTM)1.14
EY3.35%
EPS(NY)0.94
Fwd EY2.77%
FCF(TTM)1.37
FCFY4.04%
OCF(TTM)1.98
OCFY5.82%
SpS14.88
BVpS5.64
TBVpS4.79
PEG (NY)0.67
PEG (5Y)N/A
Graham Number12.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROCE | 15.21% | ||
| ROIC | 10.86% | ||
| ROICexc | 13.78% | ||
| ROICexgc | 15.4% | ||
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% | ||
| FCFM | 9.23% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)7.05%
ROICexc(5y)N/A
ROICexgc(3y)7.97%
ROICexgc(5y)N/A
ROCE(3y)7.15%
ROCE(5y)N/A
ROICexgc growth 3Y41.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y37.09%
ROICexc growth 5YN/A
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Debt/EBITDA | 0.58 | ||
| Cap/Depr | 87.82% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 11.6 | ||
| Cash Conversion | 88.25% | ||
| Profit Quality | 118.43% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 4.22 |
F-Score6
WACC8.41%
ROIC/WACC1.29
Cap/Depr(3y)259.47%
Cap/Depr(5y)259.17%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128%
EPS 3Y28.35%
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y44.42%
EPS Next 2Y12.83%
EPS Next 3Y12.5%
EPS Next 5YN/A
Revenue 1Y (TTM)14.56%
Revenue growth 3Y29.79%
Revenue growth 5Y17.19%
Sales Q2Q%15.12%
Revenue Next Year14.42%
Revenue Next 2Y11.32%
Revenue Next 3Y10.46%
Revenue Next 5YN/A
EBIT growth 1Y85.69%
EBIT growth 3Y58.11%
EBIT growth 5YN/A
EBIT Next Year114.2%
EBIT Next 3Y30.39%
EBIT Next 5YN/A
FCF growth 1Y395.38%
FCF growth 3YN/A
FCF growth 5Y32.12%
OCF growth 1Y222.73%
OCF growth 3Y15.89%
OCF growth 5Y31.61%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 6 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 4 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Fairly Valued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 29.84 and the Price/Book (PB) ratio is 6.03.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to grow by 44.42% in the next year.